How Smart Investors Look at Albertsons Companies (ACI).

Large-cap Consumer Defensive company Albertsons Companies has moved 0.2% so far today on a volume of 194,201, compared to its average of 4,943,362. In contrast, the S&P 500 index moved 1.0%.

Albertsons Companies trades -30.59% away from its average analyst target price of $30.09 per share. The 14 analysts following the stock have set target prices ranging from $21 to $42, and on average have given Albertsons Companies a rating of hold.

Anyone interested in buying ACI should be aware of the facts below:

  • Albertsons Companies's current price is 85.6% above its Graham number of $11.25, which implies that at its current valuation it does not offer a margin of safety

  • Based on its trailing earning per share of 1.1, Albertsons Companies has a trailing 12 month Price to Earnings (P/E) ratio of 19.0 while the S&P 500 average is 15.97

  • ACI has a forward P/E ratio of 8.3 based on its forward 12 month price to earnings (Eps) of $2.52 per share

  • The company has a price to earnings growth (PEG) ratio of 0.85 — a number near or below 1 signifying that Albertsons Companies is fairly valued compared to its estimated growth potential

  • Its Price to Book (P/B) ratio is 5.0 compared to its sector average of 4.09

  • Albertsons Companies, Inc., through its subsidiaries, engages in the operation of food and drug stores in the United States.

  • Based in Boise, ID, the company has 101,500 full time employees and a market cap of $9,755,906,048. Albertsons Companies currently returns an annual dividend yield of 1.9%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.